As of 2026-03-29, 肝益莱 (Livereliv)'s data on the DeepSeek platform in the 医疗保健 category shows: The overall mention rate is 0.00%, below the industry average by 3.3 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 肝益莱 (Livereliv)'s overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
肝益莱 (Livereliv)'s Mention Rate is 0.00%, lower than 0.6% of competitors
肝益莱 (Livereliv)'s First Mention is 0.00%, lower than 0.9% of competitors
肝益莱 (Livereliv)'s Preferred Rate is 0.00%, lower than 100.0% of competitors
肝益莱 (Livereliv)'s Positive Rate is 0.00%, lower than 8.9% of competitors
肝益莱 (Livereliv)'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 强强生 | 37.5% | 16.07% | 19.05% | 32.14% | 3.57% | View Details |
| 汤汤臣倍健 | 23.21% | 0% | 0% | 21.43% | 7.14% | View Details |
| 罗罗氏 | 21.43% | 0% | 0% | 14.29% | 0% | View Details |
| SSwisse | 17.86% | 5.36% | 4.76% | 14.29% | 3.57% | View Details |
| 诺诺特兰德 | 16.07% | 5.36% | 0% | 16.07% | 8.93% | View Details |
| 诺诺和诺德 | 16.07% | 0% | 0% | 8.93% | 3.57% | View Details |
| 肝肝益莱 (Livereliv) (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
